Trial Profile
Efficacy and Safety of Interferon Based Therapy and Interferon-free Direct-acting Antivirals in Cirrhotic Patients With Hepatitis C. Impact of Antiviral Therapy on Gastroesophageal Varices.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Boceprevir (Primary) ; Daclatasvir (Primary) ; Ledipasvir/sofosbuvir (Primary) ; Ombitasvir/paritaprevir/ritonavir (Primary) ; Peginterferon alfa-2a (Primary) ; Ribavirin (Primary) ; Simeprevir (Primary) ; Sofosbuvir (Primary) ; Telaprevir (Primary)
- Indications Hepatitis C; Liver cirrhosis
- Focus Therapeutic Use
- 18 May 2018 Status changed from active, no longer recruiting to completed.
- 29 Mar 2017 Planned End Date changed from 1 Oct 2016 to 15 Oct 2017.
- 18 Jul 2016 New trial record